Belimumab (trade name Benlysta) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment ...
Aug 29, 2012
0
0
For patients with systemic lupus erythematosus (SLE), iberdomide at a higher dose is superior to placebo for the rate of response indicating reduction in disease activity, according to a study published in the March 17 issue ...
Mar 17, 2022
0
15
(HealthDay)—Several subgroups of patients with cutaneous lupus erythematosus (CLE) are deficient in their use of photoprotection, according to a study published in the June issue of the Journal of the American Academy of ...
Jul 18, 2013
0
0
High rates of systemic lupus erythematosus have been linked to living in proximity to a former uranium ore processing facility in Ohio, according to new research findings presented this week at the American College of Rheumatology ...
Nov 13, 2012
1
0
For patients with systemic lupus erythematosus (SLE) refractory to conventional treatment, belimumab after rituximab significantly reduces serum immunoglobulin (Ig)G anti-double stranded DNA (dsDNA) levels and the risk for ...
Oct 26, 2021
0
2
Experts in the endothelin system are investigating how regulation of this system can serve to improve diseases of inflammation such as lupus. Endothelins are a class of peptides that play a role in regulating blood pressure. ...
Oct 4, 2021
0
0
New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions ...
Nov 6, 2020
0
1
(Medical Xpress)—A new study is currently exploring why Indigenous Australians (IA) suffer more frequently and severely from lupus than non-Indigenous Australians (NIA).
Dec 14, 2012
0
0
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) found a doubled risk of pre-malignant cervical changes, and potentially also an increased risk of cervical cancer, ...
Jun 9, 2016
0
1
Dihydroartemisinin (DHA), an active metabolite of artemisinin and the most potent anti-malaria drug, is also used to treat autoimmune diseases such as systemic lupus erythematosus (SLE) and psoriasis. Since the first report ...
Mar 28, 2022
0
0
